INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MediaAlpha, Inc. - MAX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MediaAlpha, Inc. - MAX INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MediaAlpha...
PR Newswire·5h ago
More News
Symbotic Trades Near 52-Week High: Is the Stock Still a Buy?
SYM trades near its 52-week high after a 204.5% surge this year, driven by strong backlog, solid guidance and a key robotics deal.
Zacks·6d ago
5 Technology Services Stocks to Buy for Stellar Returns in Q4
APP, SKIL, AYI, BYRN and MAX are poised to shine as the thriving Technology Services industry heads into Q4.
Zacks·8d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MediaAlpha, Inc. - MAX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MediaAlpha, Inc. - MAX INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MediaAlpha...
PR Newswire·10d ago
Are Options Traders Betting on a Big Move in MediaAlpha Stock?
Investors need to pay close attention to MAX stock based on the movements in the options market lately.
Zacks·10d ago
Symbotic's Premium Valuation: Buy, Hold or Sell the Stock Now?
Symbotic's expensive valuation, its dependence on Walmart, and unimpressive earnings history pose some tough questions for investors.
Zacks·2mo ago
Symbotic Stock Surges 134.5% YTD: Should You Buy Now or Wait?
SYM has soared 134.5% YTD on strong backlog and faster deployments, but valuation and other risks temper the buy case.
Zacks·2mo ago
MediaAlpha (MAX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for MediaAlpha (MAX) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·3mo ago
MediaAlpha, Inc. (MAX) Beats Q2 Earnings and Revenue Estimates
MediaAlpha (MAX) delivered earnings and revenue surprises of +6.25% and +2.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
Symbiotic Set to Report Q3 Earnings: Buy, Sell or Hold the Stock?
SYM gears up to report third-quarter fiscal 2025 earnings with rising revenues, soaring stock and strong backlog. Read on to find out whether you should buy, sell or hold.